{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:37:04Z","timestamp":1792575424197,"version":"4.5.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,4,15]]},"DOI":"10.2169\/internalmedicine.4162-24","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T22:10:24Z","timestamp":1725401424000},"page":"1205-1210","source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness of Additional Immunosuppressive Drugs for Corticosteroid-refractory Immune Checkpoint Inhibitor-induced Myocarditis: Two Case Reports"],"prefix":"10.2169","volume":"64","author":[{"given":"Hiroyuki","family":"Sakaguchi","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Kanazawa University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Nanjo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanazawa University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kanazawa University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kotani","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kanazawa University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kanazawa University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaname","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kanazawa University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushiro","family":"Ohtsubo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kanazawa University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Shimojima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanazawa University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kanazawa University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Schneider BJ, Naidoo J, Santomasso BD, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. J Clin Oncol 39: 4073-4126, 2021.","DOI":"10.1200\/JCO.21.01440"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ganatra S, Neilan TG. Immune checkpoint inhibitor-associated myocarditis. Oncologist 23: 879-886, 2018.","DOI":"10.1634\/theoncologist.2018-0130"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Salem JE, Manouchehri A, Moey M, et al. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol 19: 1579-1589, 2018.","DOI":"10.1016\/S1470-2045(18)30608-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nguyen LS, Cooper LT, Kerneis M, et al. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat Commun 13: 25, 2022.","DOI":"10.1038\/s41467-021-27631-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Postow MA, Callahan MK, Wolchok JD. Immune checkpoint blockade in cancer therapy. J Clin Oncol 33: 1974-1982, 2015.","DOI":"10.1200\/JCO.2014.59.4358"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Atallah-Yunes SA, Kadado AJ, Kaufman GP, Hernandez-Montfort J. Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases. J Cancer Res Clin Oncol 145: 1527-1557, 2019.","DOI":"10.1007\/s00432-019-02927-x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wang H, Tian R, Gao P, Wang Q, Zhang L. Tocilizumab for fulminant programmed death 1 inhibitor-associated myocarditis. J Thorac Oncol 15: e31-e32, 2020.","DOI":"10.1016\/j.jtho.2019.09.080"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Imai R, Ono M, Nishimura N, Suzuki K, Komiyama N, Tamura T. Fulminant myocarditis caused by an immune checkpoint inhibitor: a case report with pathologic findings. J Thorac Oncol 14: e36-e38, 2019.","DOI":"10.1016\/j.jtho.2018.10.156"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Frigeri M, Meyer P, Banfi C, et al. Immune checkpoint inhibitor-associated myocarditis: a new challenge for cardiologists. Can J Cardiol 34: 92. e91-92. e93, 2018.","DOI":"10.1016\/j.cjca.2017.09.025"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yanase T, Moritoki Y, Kondo H, Ueyama D, Akita H, Yasui T. Myocarditis and myasthenia gravis by combined nivolumab and ipilimumab immunotherapy for renal cell carcinoma: a case report of successful management. Urol Case Rep 34: 101508, 2021.","DOI":"10.1016\/j.eucr.2020.101508"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wang C, Lin J, Wang Y, et al. Case series of steroid-resistant immune checkpoint inhibitor associated myocarditis: a comparative analysis of corticosteroid and tofacitinib treatment. Front Pharmacol 12: 770631, 2021.","DOI":"10.3389\/fphar.2021.770631"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Salem JE, Bretagne M, Abbar B, et al. Abatacept\/ruxolitinib and screening for concomitant respiratory muscle failure to mitigate fatality of immune-checkpoint inhibitor myocarditis. Cancer Discov 13: 1100-1115, 2023.","DOI":"10.1158\/2159-8290.CD-22-1180"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Thomson AW, Bonham CA, Zeevi A. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit 17: 584-591, 1995.","DOI":"10.1097\/00007691-199512000-00007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fiebiger BM, Maamary J, Pincetic A, Ravetch JV. Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs. Proc Natl Acad Sci U S A 112: E2385-E2394, 2015.","DOI":"10.1073\/pnas.1505292112"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Trinath J, Hegde P, Sharma M, et al. Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells. Blood 122: 1419-1427, 2013.","DOI":"10.1182\/blood-2012-11-468264"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. De Groot AS, Moise L, McMurry JA, et al. Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". Blood 112: 3303-3311, 2008.","DOI":"10.1182\/blood-2008-02-138073"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hori A, Fujimura T, Murakami M, Park J, Kawamoto S. Intravenous immunoglobulin (IVIg) acts directly on conventional T cells to suppress T cell receptor signaling. Biochem Biophys Res Commun 522: 792-798, 2020.","DOI":"10.1016\/j.bbrc.2019.11.169"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Aggarwal R, Charles-Schoeman C, Schessl J, et al. Trial of intravenous immune globulin in dermatomyositis. N Engl J Med 387: 1264-1278, 2022.","DOI":"10.1056\/NEJMoa2117912"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Brunet M, van Gelder T, \u00c5sberg A, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit 41: 261-307, 2019.","DOI":"10.1097\/FTD.0000000000000640"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Norwood TG, Lenneman CA, Westbrook BC, Litovsky SH, McKee SB, Conry RM. Evolution of immune checkpoint blockade-induced myocarditis over 2 years. JACC Case Rep 2: 203-209, 2020.","DOI":"10.1016\/j.jaccas.2019.11.076"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Arangalage D, Delyon J, Lermuzeaux M, et al. Survival after fulminant myocarditis induced by immune-checkpoint inhibitors. Ann Intern Med 167: 683-684, 2017.","DOI":"10.7326\/L17-0396"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Norwood TG, Westbrook BC, Johnson DB, et al. Smoldering myocarditis following immune checkpoint blockade. J Immunother Cancer 5: 91, 2017.","DOI":"10.1186\/s40425-017-0296-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/8\/64_4162-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T03:29:52Z","timestamp":1745033392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/8\/64_4162-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4162-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"article-number":"4162-24"}}